BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 22697800)

  • 1. Rituximab therapy in pulmonary alveolar proteinosis improves alveolar macrophage lipid homeostasis.
    Malur A; Kavuru MS; Marshall I; Barna BP; Huizar I; Karnekar R; Thomassen MJ
    Respir Res; 2012 Jun; 13(1):46. PubMed ID: 22697800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lentivirus-ABCG1 instillation reduces lipid accumulation and improves lung compliance in GM-CSF knock-out mice.
    Malur A; Huizar I; Wells G; Barna BP; Malur AG; Thomassen MJ
    Biochem Biophys Res Commun; 2011 Nov; 415(2):288-93. PubMed ID: 22033401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ABCG1 is deficient in alveolar macrophages of GM-CSF knockout mice and patients with pulmonary alveolar proteinosis.
    Thomassen MJ; Barna BP; Malur AG; Bonfield TL; Farver CF; Malur A; Dalrymple H; Kavuru MS; Febbraio M
    J Lipid Res; 2007 Dec; 48(12):2762-8. PubMed ID: 17848583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeted PPAR{gamma} deficiency in alveolar macrophages disrupts surfactant catabolism.
    Baker AD; Malur A; Barna BP; Ghosh S; Kavuru MS; Malur AG; Thomassen MJ
    J Lipid Res; 2010 Jun; 51(6):1325-31. PubMed ID: 20064973
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restoration of PPARγ reverses lipid accumulation in alveolar macrophages of GM-CSF knockout mice.
    Malur A; Baker AD; McCoy AJ; Wells G; Barna BP; Kavuru MS; Malur AG; Thomassen MJ
    Am J Physiol Lung Cell Mol Physiol; 2011 Jan; 300(1):L73-80. PubMed ID: 21036914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An open-label trial of rituximab therapy in pulmonary alveolar proteinosis.
    Kavuru MS; Malur A; Marshall I; Barna BP; Meziane M; Huizar I; Dalrymple H; Karnekar R; Thomassen MJ
    Eur Respir J; 2011 Dec; 38(6):1361-7. PubMed ID: 21478218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alveolar macrophages of GM-CSF knockout mice exhibit mixed M1 and M2 phenotypes.
    Dalrymple H; Barna BP; Malur A; Malur AG; Kavuru MS; Thomassen MJ
    BMC Immunol; 2013 Sep; 14():41. PubMed ID: 24044676
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated gelatinase activity in pulmonary alveolar proteinosis: role of macrophage-colony stimulating factor.
    Bonfield TL; Swaisgood CM; Barna BP; Farver CF; Kavuru MS; Thomassen MJ
    J Leukoc Biol; 2006 Jan; 79(1):133-9. PubMed ID: 16275889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor.
    Bonfield TL; Raychaudhuri B; Malur A; Abraham S; Trapnell BC; Kavuru MS; Thomassen MJ
    Am J Physiol Lung Cell Mol Physiol; 2003 Nov; 285(5):L1132-6. PubMed ID: 12896880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-derived granulocyte/macrophage colony-stimulating factor autoantibodies reproduce pulmonary alveolar proteinosis in nonhuman primates.
    Sakagami T; Beck D; Uchida K; Suzuki T; Carey BC; Nakata K; Keller G; Wood RE; Wert SE; Ikegami M; Whitsett JA; Luisetti M; Davies S; Krischer JP; Brody A; Ryckman F; Trapnell BC
    Am J Respir Crit Care Med; 2010 Jul; 182(1):49-61. PubMed ID: 20224064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SP-D counteracts GM-CSF-mediated increase of granuloma formation by alveolar macrophages in lysinuric protein intolerance.
    Douda DN; Farmakovski N; Dell S; Grasemann H; Palaniyar N
    Orphanet J Rare Dis; 2009 Dec; 4():29. PubMed ID: 20030831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-affinity autoantibodies specifically eliminate granulocyte-macrophage colony-stimulating factor activity in the lungs of patients with idiopathic pulmonary alveolar proteinosis.
    Uchida K; Nakata K; Trapnell BC; Terakawa T; Hamano E; Mikami A; Matsushita I; Seymour JF; Oh-Eda M; Ishige I; Eishi Y; Kitamura T; Yamada Y; Hanaoka K; Keicho N
    Blood; 2004 Feb; 103(3):1089-98. PubMed ID: 14512323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct evidence that GM-CSF inhalation improves lung clearance in pulmonary alveolar proteinosis.
    Ohashi K; Sato A; Takada T; Arai T; Nei T; Kasahara Y; Motoi N; Hojo M; Urano S; Ishii H; Yokoba M; Eda R; Nakayama H; Nasuhara Y; Tsuchihashi Y; Kaneko C; Kanazawa H; Ebina M; Yamaguchi E; Kirchner J; Inoue Y; Nakata K; Tazawa R
    Respir Med; 2012 Feb; 106(2):284-93. PubMed ID: 22112784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chronic pharmacological antagonism of the GM-CSF receptor in mice does not replicate the pulmonary alveolar proteinosis phenotype but does alter lung surfactant turnover.
    Corkill DJ; Hunt AN; Hinrichs MJ; White N; Rebelatto M; Roskos L; Nys J; Scott A; Robinson MJ; Ryan P; Postle AD; Sleeman MA
    Clin Sci (Lond); 2021 Nov; 135(22):2559-2573. PubMed ID: 34778899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated IL-10 inhibits GM-CSF synthesis in pulmonary alveolar proteinosis.
    Thomassen MJ; Raychaudhuri B; Bonfield TL; Malur A; Abraham S; Barna BP; Kavuru MS
    Autoimmunity; 2003 Aug; 36(5):285-90. PubMed ID: 14567558
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoimmune pulmonary alveolar proteinosis: clinical course and diagnostic criteria.
    Ben-Dov I; Segel MJ
    Autoimmun Rev; 2014; 13(4-5):513-7. PubMed ID: 24424195
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacotherapy options in pulmonary alveolar proteinosis.
    Antoniu SA; Rajnoveanu R; Grigore M; Antohe I
    Expert Opin Pharmacother; 2020 Aug; 21(11):1359-1366. PubMed ID: 32511020
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adenovirus-mediated granulocyte-macrophage colony-stimulating factor improves lung pathology of pulmonary alveolar proteinosis in granulocyte-macrophage colony-stimulating factor-deficient mice.
    Zsengellér ZK; Reed JA; Bachurski CJ; LeVine AM; Forry-Schaudies S; Hirsch R; Whitsett JA
    Hum Gene Ther; 1998 Sep; 9(14):2101-9. PubMed ID: 9759936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies against granulocyte macrophage colony-stimulating factor are diagnostic for pulmonary alveolar proteinosis.
    Bonfield TL; Russell D; Burgess S; Malur A; Kavuru MS; Thomassen MJ
    Am J Respir Cell Mol Biol; 2002 Oct; 27(4):481-6. PubMed ID: 12356582
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alveolar proteinosis syndrome: pathogenesis, diagnosis, and management.
    Huizar I; Kavuru MS
    Curr Opin Pulm Med; 2009 Sep; 15(5):491-8. PubMed ID: 19561506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.